BamSEC and AlphaSense Join Forces
Learn More

Fate Therapeutics Inc.

NASDAQ: FATE    
Share price (12/20/24): $1.68    
Market cap (12/20/24): $191 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 11 pages Fate Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.3
from 10-Q 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.5
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 11 pages Fate Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.6
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4
from S-3 38 pages Fate Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [●], 201[●] Subordinated Debt Securities
12/34/56
EX-4
from S-3 37 pages Fate Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [●], 201[●] Senior Debt Securities
12/34/56
EX-4.2
from 10-Q 10 pages Warrant to Purchase Common Stock
12/34/56
EX-4.2
from 10-Q/A 19 pages Agreement
12/34/56
EX-4.2
from 10-Q 19 pages Stock Purchase Agreement
12/34/56
EX-4.2
from S-3 111 pages Fate Therapeutics, Inc. to [ ] Trustee Indenture Dated as of , 20 Subordinated Debt Securities
12/34/56
EX-4.1
from S-3 103 pages Fate Therapeutics, Inc. to [ ] Trustee Indenture Dated as of , 20 Senior Debt Securities
12/34/56
EX-4.1
from S-1/A 2 pages Additional Abbreviations May Also Be Used Though Not in the Above List
12/34/56
EX-4.6
from S-1 8 pages Fate Therapeutics, Inc. Convertible Promissory Note
12/34/56
EX-4.5
from S-1 6 pages Fate Therapeutics, Inc. Convertible Promissory Note
12/34/56
EX-4.4
from S-1 11 pages Warrant to Purchase Stock
12/34/56
EX-4.3
from S-1 2 pages First Amendment to Warrant to Purchase Stock Dated January 5, 2009
12/34/56
EX-4.2
from S-1 11 pages Warrant to Purchase Stock
12/34/56
EX-4
from DRS/A 6 pages Fate Therapeutics, Inc. Convertible Promissory Note
12/34/56
EX-4
from DRS 11 pages Warrant to Purchase Stock
12/34/56